HeartSciences (HSCS) Inventory (2022 - 2026)
HeartSciences (HSCS) posted quarterly Inventory of $655629.0 for Q2 2026, up 0.82% year-on-year from $650267.0 in Q2 2025, and up 0.82% on a QoQ basis from $650267.0 in Q4 2025.
HeartSciences (HSCS) Inventory (2022 - 2026) Analysis & Trends
HeartSciences (HSCS) has reported Inventory for 5 consecutive years, with $655629.0 the latest figure, recorded in Q2 2026.
- Quarterly Inventory rose 0.82% year-over-year to $655629.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $655629.0 (up 0.82% YoY) and the FY2026 annual result came in at $655629.0, up 0.82% from the prior year.
- Inventory rose to $655629.0 in Q2 2026 per HSCS's latest filing, from $650267.0 in the prior quarter.
- Over the last five years, Inventory for HSCS reached as high as $677669.0 in Q3 2022 and fell as low as $629179.0 in Q2 2024.
- A 5-year average of $661438.1 and a median of $657285.0 in 2025 frame the typical range for Inventory.
- Annual changes were most pronounced in 2024 — Inventory decreased 6.98% — and 2025, when it rose 3.35%.
- Year by year, Inventory stood at $677669.0 in 2022, then dropped by 0.42% to $674839.0 in 2023, then slipped by 3.25% to $652907.0 in 2024, then fell by 0.4% to $650267.0 in 2025, then gained by 0.82% to $655629.0 in 2026.
- According to Business Quant data, Inventory over the past three periods registered $655629.0, $650267.0, and $657285.0 for Q2 2026, Q4 2025, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.74 Bn | 176.45 Bn | 6.27 Bn | 6.99 Bn |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn | 5.42 Bn |
| 3 | Medtronic | 108.48 Bn | 99.26 Bn | 6.41 Bn | 5.95 Bn |
| 4 | Boston Scientific | 68.51 Bn | 67.05 Bn | 3.61 Bn | 3.12 Bn |
| 5 | Edwards Lifesciences | 48.32 Bn | 44.65 Bn | 1.29 Bn | 1.12 Bn |
| 6 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 693.60 Mn |
| 7 | GE HealthCare Technologies | 28.23 Bn | 25.95 Bn | 1.98 Bn | 2.35 Bn |
| 8 | Smith & Nephew | 26.90 Bn | 26.32 Bn | - | 2.12 Bn |
| 9 | Koninklijke Philips | 24.47 Bn | 21.35 Bn | 2.07 Bn | 3.64 Bn |
| 10 | HeartSciences | 6.62 Mn | 4.92 Mn | - | 655,629.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 655,629.00 |
| Dec 31, 2025 | 650,267.00 |
| Oct 31, 2025 | 657,285.00 |
| Jul 31, 2025 | 649,507.00 |
| Apr 30, 2025 | 650,267.00 |
| Jan 31, 2025 | 652,147.00 |
| Oct 31, 2024 | 652,907.00 |
| Jul 31, 2024 | 643,039.00 |
| Apr 30, 2024 | 629,179.00 |
| Jan 31, 2024 | 670,278.00 |
| Oct 31, 2023 | 674,839.00 |
| Jul 31, 2023 | 676,359.00 |
| Apr 30, 2023 | 676,359.00 |
| Jan 31, 2023 | 676,909.00 |
| Oct 31, 2022 | 677,669.00 |
| Jul 31, 2022 | 677,669.00 |
| Apr 30, 2022 | 674,139.00 |